Philips Releases Its Latest Patient Monitoring Solution in U.S.

Philips is releasing its latest Patient Monitoring solution in the U.S., a product designed to help hospitals keep track of patient monitor data as they move from one clinical area to another. The offering revolves around the company’s IntelliVue X3 transport monitor and it allows clinicians to easily combine all the data gathered i (Read more...)

Safety, efficacy balance needed for ROP treated with bevacizumab

WAILEA, Hawaii — A balance between safety and efficacy is needed when deciding whether to treat retinopathy of prematurity with bevacizumab or diode laser photocoagulation in premature newborns, a speaker here said.
Bevacizumab is a powerful suppressive agent given during a time when a lot of organ systems are developing, peaking in the systemic circulation around 2 weeks and lasting to about 8 weeks in systemic circulation, Darius M. Moshfeghi, MD, said at Retina 2018. Furthermore, neurodevelopmental abnormalities have been noted in small sick babies receiving bevacizumab in some

PROSE lens and autologous tears can treat persistent epithelial retinal defects

WAILEA, Hawaii — The combination of a scleral lens and autologous serum tears can effectively treat patients with refractory cases of persistent epithelial retinal defects, according to a speaker here.
“The PROSE (prosthetic replacement of the ocular surface ecosystem) lens has been a miracle for a lot of patients who haven’t responded to treatment for dry eye disease or some other form of ocular surface disease,” Kendall E. Donaldson, MD, MS, said at Hawaiian Eye 2018.
In a case series, three patients with persistent epithelial defects who were refractory after (Read more...)

Osher, Ocular Surgery News join forces on ‘Telling It Like It Is’

WAILEA, Hawaii, and AMELIA ISLAND, Fla. — The Wyanoke Group, parent company of SLACK Incorporated, publisher of Ocular Surgery News, has acquired Cataract Surgery: Telling It Like It Is, from Robert H. Osher, MD, the meeting’s founder and program director.
Osher announced the agreement from the podium today during the meeting in Amelia Island, Fla. The agreement is effective with the 2019 meeting.
Osher will remain the meeting’s program director. Richard L. Lindstrom, MD, Ocular Surgery News’ Chief Medical Editor, will join the meeting program committee.
Osher created the